as 12-27-2024 3:31pm EST
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.
Founded: | 2007 | Country: | United States |
Employees: | N/A | City: | REDWOOD CITY |
Market Cap: | 2.0M | IPO Year: | 2015 |
Target Price: | $5.00 | AVG Volume (30 days): | 6.1M |
Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -6.23 | EPS Growth: | N/A |
52 Week Low/High: | $0.39 - $5.45 | Next Earning Date: | 11-07-2024 |
Revenue: | $7,262,000 | Revenue Growth: | -6.26% |
Revenue Growth (this year): | -4.03% | Revenue Growth (next year): | 93.49% |
AVGR Breaking Stock News: Dive into AVGR Ticker-Specific Updates for Smart Investing
Thomson Reuters StreetEvents
2 months ago
GuruFocus.com
2 months ago
Zacks
2 months ago
Associated Press Finance
2 months ago
ACCESSWIRE
2 months ago
GuruFocus.com
2 months ago
ACCESSWIRE
2 months ago
ACCESSWIRE
2 months ago
The information presented on this page, "AVGR Avinger Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.